Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2008) | Total Docs. (3years) | Total Refs. (2008) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2008) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacology and Therapeutics | journal | 4.252 Q1 | 233 | 94 | 330 | 16214 | 3384 | 327 | 10.57 | 172.49 |  |
| 2 | Drug Resistance Updates | journal | 2.826 Q1 | 132 | 16 | 65 | 2260 | 527 | 63 | 9.17 | 141.25 | |
| 3 | Expert Opinion on Emerging Drugs | journal | 0.986 Q1 | 54 | 43 | 144 | 5144 | 459 | 144 | 3.44 | 119.63 |  |
| 4 | Drug Metabolism Reviews | journal | 1.561 Q1 | 108 | 24 | 110 | 2299 | 600 | 106 | 5.22 | 95.79 | |
| 5 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.237 Q3 | 30 | 24 | 54 | 2294 | 47 | 54 | 0.87 | 95.58 |  |
| 6 | Perspectives in Medicinal Chemistry | journal | 17 | 7 | 0 | 666 | 0 | 0 | 0.00 | 95.14 |  | |
| 7 | CNS Drugs | journal | 1.410 Q1 | 129 | 73 | 262 | 6694 | 1178 | 227 | 3.81 | 91.70 | |
| 8 | American Journal of Cardiovascular Drugs | journal | 0.761 Q2 | 60 | 38 | 136 | 3371 | 337 | 131 | 1.94 | 88.71 | |
| 9 | PPAR Research | journal | 0.747 Q2 | 59 | 117 | 52 | 9910 | 126 | 47 | 2.42 | 84.70 | |
| 10 | CNS Neuroscience and Therapeutics | journal | 91 | 31 | 0 | 2582 | 0 | 0 | 0.00 | 83.29 | | |
| 11 | Drugs | journal | 1.288 Q1 | 188 | 175 | 656 | 14388 | 2726 | 516 | 3.85 | 82.22 | |
| 12 | BioDrugs | journal | 1.121 Q1 | 79 | 38 | 123 | 3093 | 420 | 117 | 2.97 | 81.39 | |
| 13 | Neurotherapeutics | journal | 2.162 Q1 | 136 | 65 | 191 | 5266 | 1146 | 175 | 4.68 | 81.02 | |
| 14 | Methods in Pharmacology and Toxicology | book series | 14 | 22 | 0 | 1742 | 0 | 0 | 0.00 | 79.18 | | |
| 15 | Expert Review of Neurotherapeutics | journal | 0.679 Q2 | 98 | 170 | 443 | 12998 | 931 | 407 | 2.17 | 76.46 | |
| 16 | Drugs and Aging | journal | 0.823 Q2 | 109 | 83 | 251 | 6239 | 812 | 240 | 2.63 | 75.17 | |
| 17 | Expert Opinion on Pharmacotherapy | journal | 0.595 Q2 | 93 | 294 | 742 | 21461 | 1699 | 724 | 2.45 | 73.00 | |
| 18 | Expert Opinion on Investigational Drugs | journal | 1.249 Q1 | 117 | 173 | 445 | 12481 | 1750 | 418 | 3.98 | 72.14 | |
| 19 | Expert Opinion on Drug Safety | journal | 0.840 Q1 | 90 | 78 | 255 | 5538 | 750 | 213 | 2.94 | 71.00 | |
| 20 | Expert Review of Clinical Pharmacology | journal | 60 | 71 | 0 | 5038 | 0 | 0 | 0.00 | 70.96 | | |
| 21 | AIDS Reviews | journal | 1.528 Q1 | 62 | 26 | 82 | 1803 | 263 | 74 | 3.04 | 69.35 |  |
| 22 | Expert Review of Anticancer Therapy | journal | 0.837 Q2 | 85 | 178 | 469 | 12303 | 1058 | 422 | 2.36 | 69.12 | |
| 23 | Biologics: Targets and Therapy | journal | 0.105 Q4 | 47 | 89 | 48 | 6093 | 8 | 45 | 0.17 | 68.46 | |
| 24 | Therapeutic Advances in Cardiovascular Disease | journal | 0.300 Q3 | 41 | 43 | 12 | 2923 | 11 | 11 | 0.92 | 67.98 | |
| 25 | Cancer and Chemotherapy Reviews | journal | 0.101 Q4 | 4 | 14 | 20 | 951 | 0 | 20 | 0.00 | 67.93 | |
| 26 | Clinical Pharmacokinetics | journal | 1.480 Q1 | 184 | 62 | 236 | 4132 | 1372 | 224 | 5.00 | 66.65 | |
| 27 | Orphanet Journal of Rare Diseases | journal | 1.211 Q1 | 136 | 34 | 101 | 2231 | 408 | 100 | 4.04 | 65.62 | |
| 28 | Primary Care - Clinics in Office Practice | journal | 0.310 Q3 | 59 | 49 | 162 | 3213 | 188 | 150 | 0.85 | 65.57 | |
| 29 | Therapeutic Advances in Respiratory Disease | journal | 0.188 Q3 | 50 | 34 | 10 | 2229 | 12 | 8 | 1.20 | 65.56 | |
| 30 | Paediatric Drugs | journal | 0.743 Q2 | 70 | 41 | 128 | 2643 | 295 | 106 | 1.85 | 64.46 | |
| 31 | Experimental and Clinical Psychopharmacology | journal | 1.157 Q1 | 101 | 56 | 149 | 3445 | 357 | 148 | 2.48 | 61.52 | |
| 32 | Cardiovascular Therapeutics | journal | 54 | 32 | 0 | 1922 | 0 | 0 | 0.00 | 60.06 | | |
| 33 | Side Effects of Drugs Annual | book series | 0.103 Q4 | 9 | 52 | 101 | 3058 | 3 | 52 | 0.00 | 58.81 | |
| 34 | Vascular Health and Risk Management | journal | 0.423 Q2 | 82 | 160 | 214 | 9254 | 297 | 206 | 1.33 | 57.84 | |
| 35 | Drugs of the Future | journal | 0.281 Q3 | 46 | 119 | 850 | 6826 | 210 | 337 | 0.60 | 57.36 | |
| 36 | Therapeutics and Clinical Risk Management | journal | 0.174 Q3 | 70 | 146 | 173 | 8343 | 101 | 162 | 0.58 | 57.14 | |
| 37 | Drug Metabolism and Personalized Therapy | journal | 0.185 Q3 | 38 | 19 | 35 | 1084 | 26 | 34 | 0.78 | 57.05 |  |
| 38 | International Journal of Neuropsychopharmacology | journal | 1.843 Q1 | 125 | 109 | 258 | 5846 | 1071 | 226 | 3.88 | 53.63 | |
| 39 | American Journal of Pharmacology and Toxicology (discontinued) | journal | 0.108 Q4 | 24 | 23 | 21 | 1231 | 3 | 21 | 0.14 | 53.52 | |
| 40 | Future HIV Therapy | journal | 8 | 57 | 0 | 3017 | 0 | 0 | 0.00 | 52.93 | | |
| 41 | Current Treatment Options in Oncology | journal | 0.767 Q2 | 66 | 35 | 135 | 1847 | 319 | 135 | 2.37 | 52.77 | |
| 42 | Journal of Psychiatry and Neuroscience | journal | 1.542 Q1 | 114 | 56 | 146 | 2947 | 516 | 120 | 3.48 | 52.63 |  |
| 43 | Drug Target Insights | journal | 16 | 14 | 0 | 736 | 0 | 0 | 0.00 | 52.57 |  | |
| 44 | European Neuropsychopharmacology | journal | 1.507 Q1 | 130 | 117 | 279 | 6132 | 1230 | 274 | 3.72 | 52.41 | |
| 45 | Cochrane Database of Systematic Reviews | journal | 1.353 Q1 | 327 | 1051 | 2215 | 54427 | 10056 | 2214 | 4.01 | 51.79 | |
| 46 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.641 Q2 | 57 | 29 | 112 | 1475 | 207 | 104 | 1.83 | 50.86 | |
| 47 | Drugs of Today | journal | 0.618 Q2 | 57 | 102 | 240 | 5033 | 519 | 238 | 2.02 | 49.34 | |
| 48 | Fundamental and Clinical Pharmacology | journal | 0.732 Q2 | 85 | 76 | 229 | 3644 | 585 | 223 | 2.37 | 47.95 | |
| 49 | Inflammopharmacology | journal | 0.408 Q2 | 68 | 40 | 148 | 1893 | 191 | 142 | 1.17 | 47.33 |  |
| 50 | Targeted Oncology | journal | 0.351 Q2 | 59 | 33 | 63 | 1561 | 35 | 56 | 0.56 | 47.30 |  |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data